Monday, January 26, 2026 3:11:19 AM
UPDATE
The only change so far is the trading status changed from 'Normal - closed' to:-
Trading Status: Normal - Opening Auction Call
52 week range showing
1.31 / 1.31
UPDATE Now past the official opening time !with delayed data) and showing :-
Trading Status: Normal - Periodic Auction Call
Key Aspects of LSE Periodic Auction Calls
Trading System: Primarily used in SETSqx (Stock Exchange Trading System quote-driven) to combine order-driven auctions with market maker quotes.
Auction Structure:
Call Period: Participants submit buy/sell orders, visible during this phase.
Uncrossing: A single price is calculated that maximizes executable volume.
Random End: The auction ends randomly within a 30-second window to prevent market manipulation.
Daily Schedule (SETSqx):
Opening Auction: 07:50 – 08:00 (followed by uncrossing).
Intra-day Auctions: Three scheduled auctions, typically at 08:50, 10:50, 12:50, 14:50 (times may vary slightly).
Closing Auction: 16:30 – 16:35.
Price Monitoring Extensions: If the auction price falls outside pre-set parameters, the call period is automatically extended by 5 minutes, up to two times, to allow for price stability.
SETSqx Trading System vs. Continuous Trading: Unlike Continuous Limit Order Books (CLOBs), periodic auctions gather liquidity, reducing transaction costs for smaller orders.
As at 26.01.26 08:00:13 GMT - All data delayed at least 15 minutes
https://www.londonstockexchange.com/market-stock/0K95/northwest-biotherapeutics-inc/overview
The only change so far is the trading status changed from 'Normal - closed' to:- Trading Status: Normal - Opening Auction Call
52 week range showing
1.31 / 1.31
UPDATE Now past the official opening time !with delayed data) and showing :-
Trading Status: Normal - Periodic Auction Call
Key Aspects of LSE Periodic Auction Calls
Trading System: Primarily used in SETSqx (Stock Exchange Trading System quote-driven) to combine order-driven auctions with market maker quotes.
Auction Structure:
Call Period: Participants submit buy/sell orders, visible during this phase.
Uncrossing: A single price is calculated that maximizes executable volume.
Random End: The auction ends randomly within a 30-second window to prevent market manipulation.
Daily Schedule (SETSqx):
Opening Auction: 07:50 – 08:00 (followed by uncrossing).
Intra-day Auctions: Three scheduled auctions, typically at 08:50, 10:50, 12:50, 14:50 (times may vary slightly).
Closing Auction: 16:30 – 16:35.
Price Monitoring Extensions: If the auction price falls outside pre-set parameters, the call period is automatically extended by 5 minutes, up to two times, to allow for price stability.
SETSqx Trading System vs. Continuous Trading: Unlike Continuous Limit Order Books (CLOBs), periodic auctions gather liquidity, reducing transaction costs for smaller orders.
As at 26.01.26 08:00:13 GMT - All data delayed at least 15 minutes
https://www.londonstockexchange.com/market-stock/0K95/northwest-biotherapeutics-inc/overview
Bullish
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
